GLP-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: THERAPEUTIC POTENTIAL AND CLINICAL CHALLENGES. IJITSS [Internet]. 2025 Jul. 22 [cited 2026 Mar. 17];1(3(47). Available from: https://rspublisher.org/index.php/ijitss/article/view/3493